High-dose DICEP chemotherapy versus observation in metastatic breast cancer patients with monotopic disease responding to induction chemotherapy with paclitaxel plus epirubicin. Final results of a phase III GEICAM trial

1. Martín, M.
2. García-Puche, J.L.
3. Casado, A.
4. Del Carmen Talavera, M.
5. Menéndez, M.D.
6. Alba, E.
7. Pelegrí, A.
8. Balil, A.
9. Rodríguez-Lescure, A.
10. Casinello, J.
11. Lozano, A.M.
12. Pérez-Carrión, R.
13. Virizuela, J.A.
14. Aranda, E.
15. Oltra, A.
16. Díaz-Rubio, E.